AN UNBIASED VIEW OF NEW ENERGY

Biotech firms that happen to be unprofitable are susceptible to not getting sufficient cash to successfully fund medical research and full regulatory filings to convey a new drug to current market. With over three billion electric automobiles (EVs) about the road and three terawatt-hours (TWh) of battery storage deployed within the NZE in 2050,